000 | 01928 a2200589 4500 | ||
---|---|---|---|
005 | 20250515224347.0 | ||
264 | 0 | _c20110525 | |
008 | 201105s 0 0 eng d | ||
022 | _a1468-1331 | ||
024 | 7 |
_a10.1111/j.1468-1331.2010.03103.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLambrinoudaki, I | |
245 | 0 | 0 |
_aBsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy. _h[electronic resource] |
260 |
_bEuropean journal of neurology _cJan 2011 |
||
300 |
_a93-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAbsorptiometry, Photon |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 |
_aAnticonvulsants _xtherapeutic use |
650 | 0 | 4 |
_aBone Density _xgenetics |
650 | 0 | 4 | _aCalcium, Dietary |
650 | 0 | 4 |
_aCarbamazepine _xanalogs & derivatives |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLevetiracetam |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOxcarbazepine |
650 | 0 | 4 |
_aPiracetam _xanalogs & derivatives |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 |
_aPremenopause _xgenetics |
650 | 0 | 4 |
_aReceptors, Calcitriol _xgenetics |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 |
_aValproic Acid _xtherapeutic use |
700 | 1 | _aKaparos, G | |
700 | 1 | _aArmeni, E | |
700 | 1 | _aAlexandrou, A | |
700 | 1 | _aDamaskos, C | |
700 | 1 | _aLogothetis, E | |
700 | 1 | _aCreatsa, M | |
700 | 1 | _aAntoniou, A | |
700 | 1 | _aKouskouni, E | |
700 | 1 | _aTriantafyllou, N | |
773 | 0 |
_tEuropean journal of neurology _gvol. 18 _gno. 1 _gp. 93-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-1331.2010.03103.x _zAvailable from publisher's website |
999 |
_c19853535 _d19853535 |